AI English summary of an SEC filing — figures as filed
International Flavors & Fragrances announced that Jesus Mantas and Paul Fribourg have been appointed to the board of directors, effective July 29, 2025. The Company's board determined that both qualify as independent directors under New York Stock Exchange rules and the Company's board independence requirements.
Key points
AI summaryInternational Flavors & Fragrances announced that Jesus Mantas and Paul Fribourg have been appointed to the board of directors, effective July 29, 2025. The Company's board determined that both qualify as independent directors under New York Stock Exchange rules and the Company's board independence requirements.
The company said that as of the Effective Date, Mr. Mantas has been named to the Board's Audit Committee and Innovation Committee, while Mr. Fribourg has been named to the Board's Transaction Committee.
The Company said Mantas, 56, served as Global Managing Partner leading the $10B Business Transformation Services unit in IBM Consulting and currently serves as Chair of the Compensation and Management Development Committee on Biogen Inc.'s board. Fribourg, 71, has served as Chairman and Chief Executive Officer of Continental Grain Company since 1976.
The Company said the appointments of the two directors were not made pursuant to any arrangement or understanding with any other persons, and there has been no transaction in which the Company was or is to be a participant with an amount exceeding $120,000 in which either director had or will have a direct or indirect material interest. Both will participate in the non-employee director compensation arrangements described in the Company's 2024 Proxy Statement filed on March 18, 2025.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Board Appoints 2 New Directors
International Flavors & Fragrances announced that Jesus Mantas and Paul Fribourg have been appointed to the board of directors, effective July 29, 2025. The Company's board determined that both qualify as independent directors under New York Stock Exchange rules and the Company's board independence requirements.
Source · Based on the filing body and exhibits
Committee Assignments
The company said that as of the Effective Date, Mr. Mantas has been named to the Board's Audit Committee and Innovation Committee, while Mr. Fribourg has been named to the Board's Transaction Committee.
Source · Based on the filing body and exhibits
Background of New Directors
The Company said Mantas, 56, served as Global Managing Partner leading the $10B Business Transformation Services unit in IBM Consulting and currently serves as Chair of the Compensation and Management Development Committee on Biogen Inc.'s board. Fribourg, 71, has served as Chairman and Chief Executive Officer of Continental Grain Company since 1976.
Source · Based on the filing body and exhibits
Appointment Circumstances and Director Compensation
The Company said the appointments of the two directors were not made pursuant to any arrangement or understanding with any other persons, and there has been no transaction in which the Company was or is to be a participant with an amount exceeding $120,000 in which either director had or will have a direct or indirect material interest. Both will participate in the non-employee director compensation arrangements described in the Company's 2024 Proxy Statement filed on March 18, 2025.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…